BrightGene Bio-Medical Technology funding history / development milestones

IPO上市，

2019.11.08，上交所

定向增发，55000万人民币

2019.01.07, 广发乾和投资, 弘晖资本

Note: collected from public online reports, for reference only.

Talent Demand Trend Analysis More

医药

生物医药

新药研发

原料药

制药/药业

创新药

抗肿瘤药

心血管药

药物研发

恩替卡韦

仿制药

抗生素

超级抗生素

降糖药

多肽

People who follow BrightGene Bio-Medical Technology also follow

BrightGene Bio-Medical Technology Competitors (Similar Companies)

Follow in Bulk Copy Company Names

Innovent Biologics (Suzhou) Co., Ltd.

“To develop high-quality biologics that are accessible and affordable f”

Suzhou Zelgen Biopharmaceuticals Co., Ltd.

“Committed to the independent R&D, production, and sales of innovative ”

Jiangsu Hengrui Pharmaceuticals Co., Ltd.

“Research, development, and production of anti-tumor and surgical medic”

Pfizer Investment Co., Ltd.

“Continuously innovating to bring patients medicines that significantly”

Suzhou NanoMicro Technology Co., Ltd.

“Specializing in R&D, production, and sales of high-precision, high-per”

Wuxi WuXi Biologics Co., Ltd.

“Accelerating global biologic drug R&D processes, reducing R&D costs, a”

苏州宜联生物医药有限公司

“为全球肿瘤患者带来更好的治疗方案”

Lilly Suzhou Pharmaceutical Co., Ltd.

“To make people live longer, healthier, and more vital lives”

昭衍（苏州）新药研究中心有限公司

医药药效学研究生物制品生物医药

赛业（苏州）生物科技有限公司

生命科学生物信息生物制药干细胞

苏州昊帆生物股份有限公司

“缩合试剂、保护试剂等多肽化学品制造商和供应商”

Suzhou Shengdiya Biomedical Co., Ltd.

医药生物医药创新药制药/药业

江苏浩欧博生物医药股份有限公司

生物医药自身免疫疾病诊断试剂诊断试剂

苏州盛达药业有限公司

制药/药业抗生素原料药化学制药

Suzhou Dongrui Pharmaceutical Co., Ltd.

制药/药业医药抗生素原料药

中 中文版 View this page in Chinese ›